FATE THERAPEUTICS INC Increase (Decrease) in Accounts Payable and Accrued Liabilities
FATE THERAPEUTICS INC (FATE) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$4.52 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-13
- FATE THERAPEUTICS INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $1.26M, a 159.50% increase year-over-year.
- FATE THERAPEUTICS INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$5.77M.
- FATE THERAPEUTICS INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $865.00K, a 32.06% increase year-over-year.
- FATE THERAPEUTICS INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$550.00K, a 129.40% decline year-over-year.
- FATE THERAPEUTICS INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$9.03M.
- FATE THERAPEUTICS INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$1.66M.
- FATE THERAPEUTICS INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$28.94M, a 303.06% decline from fiscal 2022.
- FATE THERAPEUTICS INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $14.25M, a 141.27% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 77 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 80 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 83 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$4.52M 10-Q · filed 2026-08-13 | -$3.65M derived: sum of 3 quarters · filed 2026-08-13 | -$4.20M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | -$5.77M 10-Q · filed 2026-05-13 | -$4.91M derived: sum of 2 quarters · filed 2026-05-13 | -$5.46M derived: sum of 3 quarters · filed 2026-05-13 | -$4.97M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | $865.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $315.00K derived: sum of 2 quarters · filed 2026-02-26 | $799.00K derived: sum of 3 quarters · filed 2026-08-13 | -$9.03M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$550.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$66.00K derived: sum of 2 quarters · filed 2026-08-13 | -$9.89M 10-Q · filed 2025-11-13 | -$9.24M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $484.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$9.34M 10-Q · filed 2026-08-13 | -$8.69M derived: sum of 3 quarters · filed 2026-08-13 | -$6.82M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | -$9.83M 10-Q · filed 2026-05-13 | -$9.17M derived: sum of 2 quarters · filed 2026-05-13 | -$7.30M derived: sum of 3 quarters · filed 2026-05-13 | -$6.98M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $655.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.53M derived: sum of 2 quarters · filed 2026-02-26 | $2.85M derived: sum of 3 quarters · filed 2026-02-26 | -$1.66M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.19M derived: sum of 2 quarters · filed 2025-11-13 | -$2.32M 10-Q · filed 2025-11-13 | -$4.21M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $320.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$4.19M 10-Q · filed 2025-08-12 | -$6.08M derived: sum of 3 quarters · filed 2025-08-12 | -$8.36M derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | -$4.51M 10-Q · filed 2025-05-13 | -$6.40M derived: sum of 2 quarters · filed 2025-05-13 | -$8.68M derived: sum of 3 quarters · filed 2025-05-13 | -$13.05M derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | -$1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | -$4.17M derived: sum of 2 quarters · filed 2025-03-05 | -$8.55M derived: sum of 3 quarters · filed 2025-03-05 | -$28.94M 10-K · filed 2025-03-05 | |||
| 2023-09-30 | -$2.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$6.65M derived: sum of 2 quarters · filed 2024-11-12 | -$27.05M 10-Q · filed 2024-11-12 | -$23.66M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | -$4.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$24.77M 10-Q · filed 2024-08-13 | -$21.38M derived: sum of 3 quarters · filed 2024-08-13 | -$11.10M derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | -$20.39M 10-Q · filed 2024-05-09 | -$17.01M derived: sum of 2 quarters · filed 2024-05-09 | -$6.73M derived: sum of 3 quarters · filed 2024-05-09 | -$2.65M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $13.67M derived: sum of 2 quarters · filed 2024-02-26 | $17.75M derived: sum of 3 quarters · filed 2024-02-26 | $14.25M 10-K · filed 2024-02-26 | |||
| 2022-09-30 | $10.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $14.36M derived: sum of 2 quarters · filed 2023-11-08 | $10.87M 10-Q · filed 2023-11-08 | $485.00K derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | $4.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $586.00K 10-Q · filed 2023-08-08 | -$9.79M derived: sum of 3 quarters · filed 2023-08-08 | -$3.06M derived: sum of 4 quarters · filed 2023-08-08 | |||
| 2022-03-31 | -$3.49M 10-Q · filed 2023-05-03 | -$13.87M derived: sum of 2 quarters · filed 2023-05-03 | -$7.14M derived: sum of 3 quarters · filed 2023-05-03 | -$4.53M derived: sum of 4 quarters · filed 2023-05-03 | |||
| 2021-12-31 | -$10.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$3.64M derived: sum of 2 quarters · filed 2023-02-28 | -$1.04M derived: sum of 3 quarters · filed 2023-02-28 | $5.91M 10-K · filed 2023-02-28 | |||
| 2021-09-30 | $6.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $9.34M derived: sum of 2 quarters · filed 2022-11-03 | $16.29M 10-Q · filed 2022-11-03 | $17.36M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | $2.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $9.55M 10-Q · filed 2022-08-03 | $10.62M derived: sum of 3 quarters · filed 2023-02-28 | $3.19M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-03-31 | $6.94M 10-Q · filed 2022-05-04 | $8.02M derived: sum of 2 quarters · filed 2023-02-28 | $586.00K derived: sum of 3 quarters · filed 2023-02-28 | $8.71M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$6.36M derived: sum of 2 quarters · filed 2023-02-28 | $1.76M derived: sum of 3 quarters · filed 2023-02-28 | -$1.55M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | -$7.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $690.00K derived: sum of 2 quarters · filed 2021-11-04 | -$2.63M 10-Q · filed 2021-11-04 | -$1.11M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | $8.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $4.80M 10-Q · filed 2021-08-04 | $6.32M derived: sum of 3 quarters · filed 2022-02-28 | $9.97M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | -$3.32M 10-Q · filed 2021-05-05 | -$1.80M derived: sum of 2 quarters · filed 2022-02-28 | $1.85M derived: sum of 3 quarters · filed 2022-02-28 | $2.22M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $5.17M derived: sum of 2 quarters · filed 2022-02-28 | $5.54M derived: sum of 3 quarters · filed 2022-02-28 | $4.28M 10-K · filed 2022-02-28 | |||
| 2019-09-30 | $3.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.02M derived: sum of 2 quarters · filed 2020-11-05 | $2.77M 10-Q · filed 2020-11-05 | $3.10M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-06-30 | $365.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$893.00K 10-Q · filed 2020-08-05 | -$557.00K derived: sum of 3 quarters · filed 2021-02-24 | $618.00K derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-03-31 | -$1.26M 10-Q · filed 2020-05-11 | -$922.00K derived: sum of 2 quarters · filed 2021-02-24 | $253.00K derived: sum of 3 quarters · filed 2021-02-24 | $2.32M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | $336.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.51M derived: sum of 2 quarters · filed 2021-02-24 | $3.58M derived: sum of 3 quarters · filed 2021-02-24 | $4.25M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $3.25M derived: sum of 2 quarters · filed 2019-11-05 | $3.92M 10-Q · filed 2019-11-05 | $5.47M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $2.74M 10-Q · filed 2019-08-06 | $4.30M derived: sum of 3 quarters · filed 2020-03-02 | $4.11M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-03-31 | $673.00K 10-Q · filed 2019-05-07 | $2.23M derived: sum of 2 quarters · filed 2020-03-02 | $2.04M derived: sum of 3 quarters · filed 2020-03-02 | $1.51M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2017-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $1.37M derived: sum of 2 quarters · filed 2020-03-02 | $834.00K derived: sum of 3 quarters · filed 2020-03-02 | $2.51M 10-K · filed 2020-03-02 | |||
| 2017-09-30 | -$184.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$720.00K derived: sum of 2 quarters · filed 2018-11-01 | $957.00K 10-Q · filed 2018-11-01 | $1.17M derived: sum of 4 quarters · filed 2019-03-05 | |||
| 2017-06-30 | -$536.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $1.14M 10-Q · filed 2018-08-06 | $1.36M derived: sum of 3 quarters · filed 2019-03-05 | $1.53M derived: sum of 4 quarters · filed 2019-03-05 | |||
| 2017-03-31 | $1.68M 10-Q · filed 2018-05-10 | $1.89M derived: sum of 2 quarters · filed 2019-03-05 | $2.07M derived: sum of 3 quarters · filed 2019-03-05 | $2.45M derived: sum of 4 quarters · filed 2019-03-05 | |||
| 2016-12-31 | $217.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | $393.00K derived: sum of 2 quarters · filed 2019-03-05 | $771.00K derived: sum of 3 quarters · filed 2019-03-05 | $1.56M 10-K · filed 2019-03-05 | |||
| 2016-09-30 | $176.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $554.00K derived: sum of 2 quarters · filed 2017-11-01 | $1.34M 10-Q · filed 2017-11-01 | $1.06M derived: sum of 4 quarters · filed 2018-03-05 | |||
| 2016-06-30 | $378.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $1.17M 10-Q · filed 2017-08-14 | $886.00K derived: sum of 3 quarters · filed 2018-03-05 | $789.00K derived: sum of 4 quarters · filed 2018-03-05 | |||
| 2016-03-31 | $790.00K 10-Q · filed 2017-05-15 | $508.00K derived: sum of 2 quarters · filed 2018-03-05 | $411.00K derived: sum of 3 quarters · filed 2018-03-05 | $998.00K derived: sum of 4 quarters · filed 2018-03-05 | |||
| 2015-12-31 | -$282.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | -$379.00K derived: sum of 2 quarters · filed 2018-03-05 | $208.00K derived: sum of 3 quarters · filed 2018-03-05 | $477.00K 10-K · filed 2018-03-05 | |||
| 2015-09-30 | -$97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $490.00K derived: sum of 2 quarters · filed 2016-11-07 | $759.00K 10-Q · filed 2016-11-07 | $686.00K derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | $587.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $856.00K 10-Q · filed 2016-08-08 | $783.00K derived: sum of 3 quarters · filed 2017-03-16 | $1.01M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | $269.00K 10-Q · filed 2016-05-09 | $196.00K derived: sum of 2 quarters · filed 2017-03-16 | $424.00K derived: sum of 3 quarters · filed 2017-03-16 | $389.00K derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | -$73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $155.00K derived: sum of 2 quarters · filed 2017-03-16 | $120.00K derived: sum of 3 quarters · filed 2017-03-16 | $163.00K 10-K · filed 2017-03-16 | |||
| 2014-09-30 | $228.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $193.00K derived: sum of 2 quarters · filed 2015-11-03 | $236.00K 10-Q · filed 2015-11-03 | $464.00K derived: sum of 4 quarters · filed 2016-03-03 | |||
| 2014-06-30 | -$35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $8.00K 10-Q · filed 2015-08-05 | $236.00K derived: sum of 3 quarters · filed 2016-03-03 | $794.00K derived: sum of 4 quarters · filed 2016-03-03 | |||
| 2014-03-31 | $43.00K 10-Q · filed 2015-05-07 | $271.00K derived: sum of 2 quarters · filed 2016-03-03 | $829.00K derived: sum of 3 quarters · filed 2016-03-03 | $2.34M derived: sum of 4 quarters · filed 2016-03-03 | $3.89M 10-Q · filed 2014-05-13 | ||
| 2013-12-31 | $228.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $786.00K derived: sum of 2 quarters · filed 2016-03-03 | $2.30M derived: sum of 3 quarters · filed 2016-03-03 | $1.58M 10-K · filed 2016-03-03 | $3.85M 10-K · filed 2014-03-17 | ||
| 2013-09-30 | $558.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $2.07M derived: sum of 2 quarters · filed 2014-11-12 | $1.35M 10-Q · filed 2014-11-12 | $2.12M derived: sum of 4 quarters · filed 2015-03-12 | $3.62M 10-Q · filed 2013-11-13 | ||
| 2013-06-30 | $1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $792.00K 10-Q · filed 2014-08-12 | $1.56M derived: sum of 3 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | -$719.00K 10-Q · filed 2014-05-13 | $49.00K derived: sum of 2 quarters · filed 2015-03-12 | |||||
| 2012-12-31 | $768.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $405.00K 10-K · filed 2015-03-12 | |||||
| 2012-09-30 | -$363.00K 10-Q · filed 2013-11-13 | ||||||
| 2011-12-31 | $134.00K 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |